futureTEKnow Company Profile
Company
OrphAI Therapeutics
Headquarters
New Haven, Connecticut, USA
Year Founded
2013
Search Tags
About Us
OrphAI Therapeutics is a clinical-stage biopharmaceutical company developing novel treatments for rare diseases and cancer using AI-driven drug discovery. The company targets amyotrophic lateral sclerosis (ALS) and has received orphan drug designation in both the US and EU.
Trending Companies
Latest Articles
futureTEKnow is focused on identifying and promoting creators, disruptors and innovators, and serving as a vital resource for those interested in the latest advancements in technology.
© 2026 All Rights Reserved.